23(48): p
It's the right dose the one where appetite is controlled, fat loss is progressing, and side effects are minimal
"Their main side effects are usually nausea and vomiting." In TRIUMPH-2, up to 11.6 percent of participants using retatrutide stopped the drug before the end of the trial due to side effects, compared with 4.9 percent of the placebo group
Once in circulation, GLP-1 travels to target tissues, including the pancreas, where it enhances insulin secretion, and the brain, where it promotes satiety
Real-world data cited in the paper suggest roughly half of patients discontinue treatment within a year of starting it a rate far higher than the trials, with their closer supervision, capture
Reduction in body weight of 25% was observed in 36% of participants on tirzepatide 15 mg vs